英赛德
INSM
96.27
-2.94
-2.96%
英赛德
US · INSM
#794 按市值排名
上市于 1970
96.27
-2.94
-2.96%
实时 - 追踪5344个代码 - 心跳于76秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了6家。
- 机构持股总比例下降了0.2个百分点。
机构持股
- 机构持股比例
- 104.05% -0.19pp
- 机构数量
- 816 -6
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund71.74%
Hedge Fund24.27%
Public Company2.51%
Private Company1.58%
Sovereign Wealth Fund1.57%
Government Pension Fund1.03%
Family Office/Trust0.68%
Individual/Insider0.62%
VC/PE Fund0.43%
主要股东 截至 2026-06-30
BlackRock
7.24% · 15.81M 股
FMR
7.00% · 15.28M 股
Vanguard Capital Management, LLC
5.13% · 11.19M 股
Vanguard Portfolio Management, LLC
4.77% · 10.41M 股
J.P. Morgan Asset Management, Inc.
4.05% · 8.84M 股
Baker Bros. Advisors LP
4.03% · 8.80M 股
Capital Research
3.77% · 8.24M 股
Darwin Global Management Limited
2.94% · 6.43M 股
Columbia Management Investment Advisers, LLC
2.83% · 6.18M 股
Orbis Investment Management Limited
2.78% · 6.08M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 10次买入 · 40次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| William Lewis | Chairperson & CEO | 0.17% |
| Melvin Sharoky | Independent Director | 0.12% |
| David Brennan | Lead Independent Director | 0.04% |
| David W. McGirr | Independent Director | 0.04% |
| Clarissa Desjardins | Independent Director | 0.03% |
| Carol Schafer | Independent Director | 0.03% |
| Roger Adsett | Chief Operating Officer | 0.03% |
| Elizabeth Anderson | Independent Director | 0.03% |
| John Wise | Chief Commercial Officer | 0.03% |
| Alfred Altomari | Independent Director | 0.03% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-08 | David Brennan | Lead Independent Director | Open Market Disposition | -25,000 | $124.00 |
| 2026-08-16 | Melvin Sharoky | Independent Director | Open Market Disposition | -5,000 | $127.53 |
| 2026-08-09 | Roger Adsett | Chief Operating Officer | Derivative Exercise and Sale | -239,850 | $13.67–133.27 |
| 2026-08-05 | Martina Flammer | Chief Medical Officer | Derivative Exercise and Sale | -27,173 | $18.95–129.40 |
| 2026-07-22 | William Lewis | Chairperson & CEO | Derivative Exercise and Sale | -10,700 | $17.16–106.43 |
| 2026-07-08 | William Lewis | Chairperson & CEO | Derivative Exercise and Sale | -10,699 | $17.16–118.52 |
| 2026-07-05 | Martina Flammer | Chief Medical Officer | Derivative Exercise and Sale | -12,302 | $19.74–110.60 |
| 2026-06-24 | William Lewis | Chairperson & CEO | Derivative Exercise and Sale | -21,398 | $17.16–106.27 |
| 2026-06-22 | Samuele Butera | Senior Vice President of Global Respiratory | Other Acquisition | +7,342 | -- |
| 2026-06-22 | Samuele Butera | Senior Vice President of Global Respiratory | Other Derivative Acquisition | +12,570 | $102.15 |
| 2026-06-21 | Michael Smith | Senior Vice President | Automatic Disposition | -1,806 | $95.82 |
| 2026-06-07 | William Lewis | Chairperson & CEO | Automatic Disposition | -6,515 | $94.03 |
| 2026-06-04 | Martina Flammer | Chief Medical Officer | Open Market Disposition | -4,424 | $102.27–103.78 |
| 2026-06-02 | William Lewis | Chairperson & CEO | Open Market Disposition | -7,605 | $102.27 |
| 2026-06-02 | Roger Adsett | Chief Operating Officer | Open Market Disposition | -2,370 | $102.27 |
| 2026-06-02 | Sara Bonstein | Chief Financial Officer | Open Market Disposition | -2,404 | $102.27 |
| 2026-06-02 | Michael Smith | Senior Vice President | Open Market Disposition | -2,159 | $102.27 |
| 2026-05-21 | Michael Smith | Senior Vice President | Automatic Disposition | -6,149 | $108.47 |
| 2026-05-17 | William Lewis | Chairperson & CEO | Automatic Disposition | -14,865 | $106.39–106.97 |
| 2026-05-17 | William Lewis | Chairperson & CEO | Derivative Exercise and Sale | -10,699 | $17.16–106.39 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
英赛德 讨论区 0 条评论